About Itrace Pharmaceutical Solutions Private Limited
Data last updated:
Itrace Pharmaceutical Solutions Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 26 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73200MH2020PTC346768. Its GSTIN is 27AAFCI8230E1ZP (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vivek Kakasaheb Nalawade and Saurabh Arun Chaudhari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Nishignadha Park C/204 Kopar Rd Nr Swami Samarth Math Dombivali, Mumbai, Maharashtra, India – 421201.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.61 Cr, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹1.8 Cr (net margin 32%) and EBITDA of ₹3.01 Cr (EBITDA margin 53.7%). Revenue has grown at a compounded annual rate (CAGR) of 64% over three years.
As per MCA filings, the company has open charges of ₹7.79 Cr on record.
For more details, the company can be reached via its website itracepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNishignadha Park C/204 Kopar Rd Nr Swami Samarth Math Dombivali, Mumbai, Maharashtra, India – 421201
- IndustryTravel and Hospitality, Consumer Professional Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Itrace Pharmaceutical Solutions Private Limited
The main business activity of Itrace Pharmaceutical Solutions is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Itrace Pharmaceutical Solutions Private Limited FY 2024 filings available
Itrace Pharmaceutical Solutions Private Limited reported revenue of ₹5.61 Cr (up 56% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Itrace Pharmaceutical Solutions Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 64% over three years, including 56% growth in the latest year. EBITDA rose 111% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Itrace Pharmaceutical Solutions Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.01 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.8 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Itrace Pharmaceutical Solutions Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 53.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 32% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Itrace Pharmaceutical Solutions are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Itrace Pharmaceutical Solutions Private Limited
Itrace Pharmaceutical Solutions Private Limited is compared with the companies closest to it by revenue in the Consumer Services industry (Professional Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Highline Building Products Private Limited | ₹5.63 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Bangalore, Karnataka, India |
| United Ocean Ship Management Private Limited | ₹5.63 Cr (FY 2018) | •••• | •••• | -34.0% | •••• | Mumbai, Maharashtra, India |
| Sprint Studio Human Insights Private Limited | ₹5.63 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Mumbai, Maharashtra, India |
| Bonita Plants and Landscapes Private Limited | ₹5.62 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Bangalore, Karnataka, India |
| Skyward Analytics Private Limited | ₹5.61 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Dhekiajuli, Assam, India |
| Itrace Pharmaceutical Solutions Private Limited this company | ₹5.61 Cr (FY 2025) | •••• | •••• | 56.0% | •••• | Mumbai, Maharashtra, India |
| Isosky Plant Engineering Private Limited | ₹5.6 Cr (FY 2023) | •••• | •••• | 185.0% | •••• | Naugarh, Uttar Pradesh, India |
| TSC Consultants India Private Limited | ₹5.59 Cr (FY 2021) | •••• | •••• | 1867.0% | •••• | Mira Road East Thane, Maharashtra, India |
| KCS Quality Inspection Private Limited | ₹5.59 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Texcarp Consulting Private Limited | ₹5.59 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Pune, Maharashtra, India |
| Surtech Asia Private Limited | ₹5.58 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Gurgaon, Haryana, India |
Peers are the five companies nearest above and the five nearest below Itrace Pharmaceutical Solutions by revenue in the Consumer Services industry (Professional Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Itrace Pharmaceutical Solutions Private Limited
Itrace Pharmaceutical Solutions Private Limited is audited by N. J. Jawker & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N. J. Jawker & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Itrace Pharmaceutical Solutions Private Limited
Itrace Pharmaceutical Solutions has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Kakasaheb Nalawade Also directs: Avpm Research Laboratory LLP | Director | 26 Sep 2020 | 6 Years 0 Months | Current |
| Saurabh Arun Chaudhari | Director | 26 Sep 2020 | 6 Years 0 Months | Current |
| Sushil Sadanand Davande | Director | 26 Sep 2020 | 6 Years 0 Months | Current |
| Atul Kakasaheb Nalavade Also directs: Avpm Research Laboratory LLP | Director | 26 Sep 2020 | 6 Years 0 Months | Current |
Ownership and Shareholding of Itrace Pharmaceutical Solutions Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Itrace Pharmaceutical Solutions Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2025 | Others | ₹1.79 Cr | Open |
| 20 Jan 2021 | Others | ₹6 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Itrace Pharmaceutical Solutions Private Limited
Itrace Pharmaceutical Solutions Private Limited has a workforce of 0 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Itrace Pharmaceutical Solutions Private Limited
Itrace Pharmaceutical Solutions Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Neha Sachin Wandare ceased to be Director on 06 Dec 2022.
Credit Ratings, Litigation & Regulatory Alerts for Itrace Pharmaceutical Solutions Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Itrace Pharmaceutical Solutions Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Itrace Pharmaceutical Solutions Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Itrace Pharmaceutical Solutions Private Limited
Itrace Pharmaceutical Solutions has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI8230E1ZP | Maharashtra | Active | 08 Oct 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Itrace Pharmaceutical Solutions Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Itrace Pharmaceutical Solutions Private Limited
Itrace Pharmaceutical Solutions is an active private limited company based in Mumbai, Maharashtra, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 26 September 2020 (6+ years old) and is registered under CIN U73200MH2020PTC346768.
Itrace Pharmaceutical Solutions reported revenue of ₹5.61 Cr for FY 2025 (up 56% YoY).
Itrace Pharmaceutical Solutions has 4 current directors:
- Vivek Kakasaheb Nalawade - Director
- Saurabh Arun Chaudhari - Director
- Sushil Sadanand Davande - Director
- Atul Kakasaheb Nalavade - Director
Itrace Pharmaceutical Solutions reported a net profit of ₹1.8 Cr (net margin 32%) and EBITDA of ₹3.01 Cr (EBITDA margin 53.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Itrace Pharmaceutical Solutions is 64% over three years. In the latest year (FY 2025) revenue rose 56%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Itrace Pharmaceutical Solutions is 27AAFCI8230E1ZP, registered in Maharashtra.
The CIN (Corporate Identification Number) of Itrace Pharmaceutical Solutions is U73200MH2020PTC346768. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Itrace Pharmaceutical Solutions was incorporated on 26 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Itrace Pharmaceutical Solutions by revenue are Highline Building Products Private Limited, United Ocean Ship Management Private Limited, Sprint Studio Human Insights Private Limited, Bonita Plants and Landscapes Private Limited, Skyward Analytics Private Limited and 5 more, all in the Consumer Services industry (Professional Services).
Neha Sachin Wandare ceased to be Director on 06 Dec 2022. Sachin Shankar Vandare ceased to be Director on 06 Dec 2022. Atul Kakasaheb Nalavade was appointed as Director on 26 Sep 2020. Itrace Pharmaceutical Solutions has 6 board changes on record in total.
Itrace Pharmaceutical Solutions can be reached through the website itracepharma.com. Its registered office is in Mumbai, Maharashtra, India.